-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS ANNOUNCES ACTIVATION OF CLINICAL TRIAL SITE AT UNIVERSITY OF ALABAMA AT BIRMINGHAM FOR ONGOING PHASE 1/1B TRIAL OF PAS-004 IN ADULT NF1 PATIENTS

Reuters·11/04/2025 12:03:00

Please log in to view news